Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 20/20 | 0.57 |
| ▸ | HRH1 | P35367 | 7/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 6/20 | 0.48 |
| ▸ | ADRA2B | P18089 | 6/20 | 0.48 |
| ▸ | ADRA2C | P18825 | 6/20 | 0.48 |
| ▸ | ADRA1D | P25100 | 13/20 | 0.44 |
| ▸ | ADRA1B | P35368 | 13/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7924068 | 0.92 | ADRA1A (0.57) | ADRA1AHRH1ADRA2AADRA2BADRA2C | |
| SCHEMBL7930708 | 0.89 | ADRA1A (0.55) | ADRA1AHRH1ADRA2AADRA2BADRA2C | |
| SCHEMBL7928708 | 0.87 | ADRA1A (0.55) | ADRA1AHRH1ADRA2AADRA2BADRA2C | |
| SCHEMBL7924097 | 0.87 | ADRA1A (0.57) | ADRA1AHRH1ADRA2AADRA2BADRA2C | |
| SCHEMBL7924086 | 0.85 | ADRA1A (0.55) | ADRA1AHRH1ADRA2AADRA2BADRA2C | |
| SCHEMBL7930750 | 0.81 | ADRA1A (0.55) | ADRA1AHRH1ADRA2AADRA2BADRA2C | |
| SCHEMBL7994822 | 0.79 | ADRA1A (0.57) | ADRA1AHRH1ADRA2AADRA2BADRA2C | |
| SCHEMBL8003866 | 0.79 | ADRA1A (0.59) | ADRA1AHRH1ADRA2AADRA2BADRA2C | |
| SCHEMBL7930721 | 0.76 | ADRA1A (0.38) | ADRA1AHRH1ADRA2AADRA2BADRA2C | |
| SCHEMBL7923884 | 0.72 | ADRA1A (1.00) | ADRA1AHRH1ADRA2AADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6235759-B1 | BENIGN PROSTATIC HYPERPLASIA; HYPOTENSIVE AGENTS | MERCK & CO., INC. | 2001-05-22 | — | — | US | disclosed |